Single shot of 17D vaccine may not confer life-long protection against yellow fever
Open Access
- 27 November 2017
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 113 (2) , 135-137
Abstract
The yellow fever (YF) vaccine has been used since the 1930s to prevent YF, which is a severe infectious disease caused by the yellow fever virus (YFV), and mainly transmitted by Culicidae mosquitoes from the genera Aedes and Haemagogus . Until 2013, the World Health Organization (WHO) recommended the administration of a vaccine dose every ten years. A new recommendation of a single vaccine dose to confer life-long protection against YFV infection has since been established. Recent evidence published elsewhere suggests that at least a second dose is needed to fully protect against YF disease. Here, we discuss the feasibility of administering multiple doses, the necessity for a new and modern vaccine, and recommend that the WHO conveys a meeting to discuss YFV vaccination strategies for people living in or travelling to endemic areas.Keywords
This publication has 9 references indexed in Scilit:
- Yellow Fever Remains a Potential Threat to Public HealthVector-Borne and Zoonotic Diseases, 2016
- Booster dose after 10 years is recommended following 17DD-YF primary vaccinationHuman Vaccines & Immunotherapeutics, 2015
- Yellow feverJournal of Clinical Virology, 2015
- Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubellaVaccine, 2011
- Yellow fever in Brazil: thoughts and hypotheses on the emergence in previously free areasRevista de Saúde Pública, 2010
- Update on progress controlling yellow fever in Africa, 2004-2008.2008
- Yellow fever: an updateThe Lancet Infectious Diseases, 2001
- Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISATropical Medicine & International Health, 1999
- THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATIONJournal of Experimental Medicine, 1937